Market Cap 573.70M
Revenue (ttm) 40,000.00
Net Income (ttm) -88.09M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -220,225.00%
Debt to Equity Ratio 0.15
Volume 16,789,195
Avg Vol 4,228,200
Day's Range N/A - N/A
Shares Out 194.47M
Stochastic %K 62%
Beta 0.21
Analysts Strong Sell
Price Target $15.45

Company Profile

Altimmune, Inc., a late clinical stage biopharmaceutical company, focuses on developing novel therapies for serious liver diseases. Its lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist, which is in Phase 3 clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis, alcohol use disorder, and alcohol-associated liver disease. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland.

Industry: Biotechnology
Sector: Healthcare
Phone: 240 654 1450
Address:
910 Clopper Road, Suite 201S, Gaithersburg, United States
Stanleydavidson
Stanleydavidson Jun. 26 at 8:59 PM
$ALT why volume almost 4x the average something is cooking hard filet mignon i think
0 · Reply
denzo2
denzo2 Jun. 26 at 8:58 PM
$ALT I predict that AUD data will be positive but underwhelming. Also that P3 initiation will not move the SP much. Oral will fade from our memories. Only a strong BO/PS will rocket the SP! Sad, but this what current scenario says to me.
0 · Reply
wildcard55
wildcard55 Jun. 26 at 8:37 PM
$ALT Alt was 3x average volume today. A good chunk of that is rebalancing, bur I don’t think it explains it all. Some of that volume is for other reasons.
1 · Reply
Hatrak1
Hatrak1 Jun. 26 at 8:30 PM
$ALT Look at the block of volume that added to the profile ! 👀
1 · Reply
lottomillions
lottomillions Jun. 26 at 8:20 PM
$ALT So many small bios up over 10% today, this has to be one of the best ever months for small biotech.
1 · Reply
Hatrak1
Hatrak1 Jun. 26 at 8:19 PM
$ALT Git the fuck outta here ! 😆
0 · Reply
Corpkcots
Corpkcots Jun. 26 at 8:18 PM
$ALT Interesting volume! Nasdaq shows the volume for the day at over 14 million shares, but when you look at the 4:00pm peak the volume is over 19 million shares. Wow! Go ALT
0 · Reply
Alexandre_300
Alexandre_300 Jun. 26 at 8:11 PM
$ALT this
0 · Reply
DarbyCash
DarbyCash Jun. 26 at 8:09 PM
$ALT does this explain the large volume?
1 · Reply
jayessbee
jayessbee Jun. 26 at 8:05 PM
$ALT rebalancing day.
1 · Reply
Latest News on ALT
Altimmune initiated with an Outperform at Leerink

2026-06-22T10:46:24.000Z - 4 days ago

Altimmune initiated with an Outperform at Leerink


Altimmune initiated with an Outperform at Leerink

2026-06-22T10:31:03.000Z - 4 days ago

Altimmune initiated with an Outperform at Leerink


Altimmune to Participate in Upcoming Investor Conferences

May 27, 2026, 8:30 AM EDT - 4 weeks ago

Altimmune to Participate in Upcoming Investor Conferences


Altimmune Slides: Corporate presentation

May 14, 2026, 7:00 AM EDT - 6 weeks ago

Altimmune Slides: Corporate presentation


Altimmune price target lowered to $11 from $14 at Citizens

2026-05-14T09:47:49.000Z - 6 weeks ago

Altimmune price target lowered to $11 from $14 at Citizens


Altimmune Earnings Call Transcript: Q1 2026

May 13, 2026, 8:30 AM EDT - 6 weeks ago

Altimmune Earnings Call Transcript: Q1 2026


Altimmune Earnings release: Q1 2026

May 13, 2026, 8:30 AM EDT - 6 weeks ago

Altimmune Earnings release: Q1 2026


Altimmune Quarterly report: Q1 2026

May 13, 2026, 8:30 AM EDT - 6 weeks ago

Altimmune Quarterly report: Q1 2026


Altimmune reports Q1 EPS (18c), consensus (25c)

2026-05-13T11:59:47.000Z - 6 weeks ago

Altimmune reports Q1 EPS (18c), consensus (25c)


Altimmune management to meet with Piper Sandler

2026-04-27T19:56:05.000Z - 2 months ago

Altimmune management to meet with Piper Sandler


Altimmune upgraded to Neutral from Sell at Goldman Sachs

2026-04-24T09:16:13.000Z - 2 months ago

Altimmune upgraded to Neutral from Sell at Goldman Sachs


Altimmune 64.25M share Spot Secondary priced at $3.00

2026-04-23T11:06:36.000Z - 2 months ago

Altimmune 64.25M share Spot Secondary priced at $3.00


Altimmune announces common stock offering, no amount given

2026-04-22T20:28:30.000Z - 2 months ago

Altimmune announces common stock offering, no amount given


Altimmune Transcript: AGM 2026

Apr 16, 2026, 8:30 AM EDT - 2 months ago

Altimmune Transcript: AGM 2026


Altimmune initiated with a Buy at Truist

2026-03-18T20:00:19.000Z - 3 months ago

Altimmune initiated with a Buy at Truist


Altimmune Proxy statement: Proxy Filing

Mar 17, 2026, 8:00 AM EDT - 3 months ago

Altimmune Proxy statement: Proxy Filing


Altimmune Transcript: Leerink Global Healthcare Conference 2026

Mar 11, 2026, 9:20 AM EDT - 3 months ago

Altimmune Transcript: Leerink Global Healthcare Conference 2026


Altimmune Transcript: The Citizens Life Sciences Conference 2026

Mar 10, 2026, 2:15 PM EDT - 3 months ago

Altimmune Transcript: The Citizens Life Sciences Conference 2026


Altimmune Slides: Corporate presentation

Mar 9, 2026, 7:00 AM EDT - 3 months ago

Altimmune Slides: Corporate presentation


Altimmune price target lowered to $13 from $18 at B. Riley

2026-03-06T13:40:07.000Z - 4 months ago

Altimmune price target lowered to $13 from $18 at B. Riley


Altimmune Proxy statement: Proxy Filing

Mar 6, 2026, 7:00 AM EST - 4 months ago

Altimmune Proxy statement: Proxy Filing


Altimmune Earnings Call Transcript: Q4 2025

Mar 5, 2026, 8:30 AM EST - 4 months ago

Altimmune Earnings Call Transcript: Q4 2025


Altimmune Annual report: Q4 2025

Mar 5, 2026, 8:30 AM EST - 4 months ago

Altimmune Annual report: Q4 2025


Altimmune Earnings release: Q4 2025

Mar 5, 2026, 8:30 AM EST - 4 months ago

Altimmune Earnings release: Q4 2025


Altimmune reports Q4 EPS (27c), consensus (24c)

2026-03-05T12:14:56.000Z - 4 months ago

Altimmune reports Q4 EPS (27c), consensus (24c)


Altimmune management to meet with Piper Sandler

2026-02-20T14:12:05.000Z - 4 months ago

Altimmune management to meet with Piper Sandler


Altimmune initiated with a Buy at Titan Partners

2026-02-13T14:55:31.000Z - 4 months ago

Altimmune initiated with a Buy at Titan Partners


Altimmune Transcript: Study Result

Dec 19, 2025, 8:00 AM EST - 6 months ago

Altimmune Transcript: Study Result


Altimmune Press release: Study Result

Dec 19, 2025, 8:00 AM EST - 6 months ago

Altimmune Press release: Study Result


Altimmune Slides: Study Result

Dec 19, 2025, 8:00 AM EST - 6 months ago

Altimmune Slides: Study Result


Altimmune Announces CEO Transition and Succession Plan

Dec 1, 2025, 7:30 AM EST - 7 months ago

Altimmune Announces CEO Transition and Succession Plan


Altimmune Registration statement: Registration Filing

Nov 13, 2025, 7:00 AM EST - 8 months ago

Altimmune Registration statement: Registration Filing


Altimmune Transcript: Stifel 2025 Healthcare Conference

Nov 12, 2025, 10:00 AM EST - 8 months ago

Altimmune Transcript: Stifel 2025 Healthcare Conference


Altimmune Slides: Corporate Presentation

Nov 6, 2025, 4:00 PM EST - 8 months ago

Altimmune Slides: Corporate Presentation


Altimmune Earnings Call Transcript: Q3 2025

Nov 6, 2025, 8:30 AM EST - 8 months ago

Altimmune Earnings Call Transcript: Q3 2025


Altimmune Quarterly report: Q3 2025

Nov 6, 2025, 8:30 AM EST - 8 months ago

Altimmune Quarterly report: Q3 2025


Altimmune Earnings release: Q3 2025

Nov 6, 2025, 8:30 AM EST - 8 months ago

Altimmune Earnings release: Q3 2025


Altimmune Registration statement: Registration Filing

Nov 6, 2025, 7:00 AM EST - 8 months ago

Altimmune Registration statement: Registration Filing


Altimmune to Participate in Two Upcoming Investor Conferences

Nov 5, 2025, 7:30 AM EST - 8 months ago

Altimmune to Participate in Two Upcoming Investor Conferences


Altimmune Transcript: Stifel Virtual Cardiometabolic Forum

Sep 30, 2025, 10:30 AM EDT - 9 months ago

Altimmune Transcript: Stifel Virtual Cardiometabolic Forum


Altimmune Transcript: AGM 2025

Sep 25, 2025, 8:30 AM EDT - 9 months ago

Altimmune Transcript: AGM 2025


Stanleydavidson
Stanleydavidson Jun. 26 at 8:59 PM
$ALT why volume almost 4x the average something is cooking hard filet mignon i think
0 · Reply
denzo2
denzo2 Jun. 26 at 8:58 PM
$ALT I predict that AUD data will be positive but underwhelming. Also that P3 initiation will not move the SP much. Oral will fade from our memories. Only a strong BO/PS will rocket the SP! Sad, but this what current scenario says to me.
0 · Reply
wildcard55
wildcard55 Jun. 26 at 8:37 PM
$ALT Alt was 3x average volume today. A good chunk of that is rebalancing, bur I don’t think it explains it all. Some of that volume is for other reasons.
1 · Reply
Hatrak1
Hatrak1 Jun. 26 at 8:30 PM
$ALT Look at the block of volume that added to the profile ! 👀
1 · Reply
lottomillions
lottomillions Jun. 26 at 8:20 PM
$ALT So many small bios up over 10% today, this has to be one of the best ever months for small biotech.
1 · Reply
Hatrak1
Hatrak1 Jun. 26 at 8:19 PM
$ALT Git the fuck outta here ! 😆
0 · Reply
Corpkcots
Corpkcots Jun. 26 at 8:18 PM
$ALT Interesting volume! Nasdaq shows the volume for the day at over 14 million shares, but when you look at the 4:00pm peak the volume is over 19 million shares. Wow! Go ALT
0 · Reply
Alexandre_300
Alexandre_300 Jun. 26 at 8:11 PM
$ALT this
0 · Reply
DarbyCash
DarbyCash Jun. 26 at 8:09 PM
$ALT does this explain the large volume?
1 · Reply
jayessbee
jayessbee Jun. 26 at 8:05 PM
$ALT rebalancing day.
1 · Reply
AllwaysInvesting
AllwaysInvesting Jun. 26 at 8:04 PM
$ALT Tutes positioning again before news breaks out.
0 · Reply
Turribull
Turribull Jun. 26 at 8:03 PM
$ALT 14,135,939 volume? This ain’t triple witching.
2 · Reply
lottomillions
lottomillions Jun. 26 at 8:02 PM
$ALT The XBI exploded upwards the last 3 minutes for some reason, bringing this with it.
1 · Reply
Hatrak1
Hatrak1 Jun. 26 at 8:01 PM
$ALT 😀
2 · Reply
AllwaysInvesting
AllwaysInvesting Jun. 26 at 8:01 PM
$ALT Wow big trades again at the close!
0 · Reply
Outatime85
Outatime85 Jun. 26 at 8:01 PM
$ALT I stand corrected. 13 million volume? Is that correct? Must have been a big transaction at the bell
1 · Reply
golfeveryday
golfeveryday Jun. 26 at 8:00 PM
$ALT MDGL took quite the tumble end of day
0 · Reply
chotis
chotis Jun. 26 at 7:51 PM
$ALT what happens first phase III start or RS?
1 · Reply
Outatime85
Outatime85 Jun. 26 at 7:49 PM
$ALT I think we all seen this coming. Have a great weekend all. Back Monday for another beating
0 · Reply
BioRich
BioRich Jun. 26 at 7:40 PM
$SLS The parallels to last year's $ALT continue. While this board likes to hype a "deal must be coming" because $SLS did some housekeeping, you fail to realize that this essentially means Execs get paid lump sum if "terminated" or "leave for good reason". They get paid EVERYTHING! If you've followed the Scammish ways of $SLS, it looks like Stooge and company are ready to cash in, and this allows them a smooth transition to pay dirt follow $SLS REGAL P3 failure. Don't forget, there's always a counter argument. You don't have to listen, you don't have to believe it, you don't have to understand it, but it's always best to acknowledge it. Follow/Subscribe for more suggestions and perspective. Would love to hear yours too. That's how we learn. Cheers!
1 · Reply
Cryptobearcat
Cryptobearcat Jun. 26 at 7:30 PM
$ALT Moment of clarity in this MASH play! Sitting here in Vic Braseria in Barcelona As I taste our first course a delicious interpretation of the traditional Foie Gras. It just occurred to me that I am eating the result of Goose MASH! Now my morbid mind is wondering where is Hannibal Lecter when you need him. Why Dr. Lecter does fatty goose liver taste like fatty human MASH liver LOLOL
2 · Reply
Whiskeyunderthebed
Whiskeyunderthebed Jun. 26 at 7:17 PM
$ALT 5. Turribull is really Jerry Durso on this board.
3 · Reply